眾生藥業(002317.SZ):回購賬户中的570萬股已過户至2022年員工持股計劃專户
格隆匯3月18日丨眾生藥業(002317.SZ)公佈,2022年3月18日,公司收到中國證券登記結算有限責任公司深圳分公司出具的《證券過户登記確認書》,公司開立的“廣東眾生藥業股份有限公司回購專用證券賬户”中所持有的570萬股公司股票已於2022年3月17日非交易過户至“廣東眾生藥業股份有限公司-2022年員工持股計劃”專户,過户股數佔公司總股本的0.70%。
根據《公司2022年員工持股計劃》的相關規定,本員工持股計劃的存續期為六年,自本員工持股計劃草案經公司股東大會審議通過且公司公吿全部標的股票過户至本員工持股計劃名下之日起計算。本員工持股計劃所獲標的股票分三期解鎖,解鎖時點分別為自公司公吿全部標的股票過户至本員工持股計劃名下之日起滿12個月、24個月、36個月,每期解鎖的標的股票比例分別為40%、30%、30%。各年度具體解鎖比例和數量根據公司業績指標和持有人考核結果計算確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.